Reported Consolidated quarterly numbers for Suven Life Sciences are:Net Sales at Rs 2.45 crore in December 2023 down 18.37% from Rs. 3.00 crore in December 2022.
Quarterly Net Loss at Rs. 41.76 crore in December 2023 up 18.29% from Rs. 51.12 crore in December 2022.
EBITDA stands negative at Rs. 40.13 crore in December 2023 up 18.73% from Rs. 49.38 crore in December 2022.
| Suven Life Sci shares closed at 108.30 on January 31, 2024 (NSE) and has given 70.02% returns over the last 6 months and 77.83% over the last 12 months. |
| Suven Life Sciences | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Dec'23 | Sep'23 | Dec'22 | | Net Sales/Income from operations | 2.45 | 3.06 | 3.00 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 2.45 | 3.06 | 3.00 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 5.79 | 4.45 | 4.76 | | Depreciation | 1.60 | 1.73 | 1.67 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | 41.62 | -- | 48.85 | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 1.23 | 22.12 | 0.98 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -47.80 | -25.24 | -53.26 | | Other Income | 6.07 | 5.14 | 2.20 | | P/L Before Int., Excpt. Items & Tax | -41.73 | -20.09 | -51.05 | | Interest | 0.04 | 0.04 | 0.06 | | P/L Before Exceptional Items & Tax | -41.76 | -20.14 | -51.12 | | Exceptional Items | -- | 7.46 | -- | | P/L Before Tax | -41.76 | -12.68 | -51.12 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -41.76 | -12.68 | -51.12 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -41.76 | -12.68 | -51.12 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -41.76 | -12.68 | -51.12 | | Equity Share Capital | 21.81 | 21.81 | 21.81 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -1.92 | -0.58 | -2.90 | | Diluted EPS | -1.92 | -0.58 | -2.90 | | EPS After Extra Ordinary | | Basic EPS | -1.92 | -0.58 | -2.90 | | Diluted EPS | -1.92 | -0.58 | -2.90 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
